medroxyprogesterone has been researched along with Bone Fractures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furberg, C; Grady, D; Herrington, D; Hulley, S; Hunninghake, D; Khan, S; Vittinghoff, E; Wenger, NK | 1 |
| Applegate, W; Barrett-Connor, E; Black, DM; Cauley, JA; Cummings, SR; Harris, F; Shields, K | 1 |
2 trial(s) available for medroxyprogesterone and Bone Fractures
| Article | Year |
|---|---|
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Topics: Aged; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Hospitalization; Humans; Leg Injuries; Medroxyprogesterone; Multivariate Analysis; Neoplasms; Proportional Hazards Models; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thrombosis | 2000 |
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS).
Topics: Aged; Body Height; Bone Density; Double-Blind Method; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Incidence; Life Style; Medroxyprogesterone; Postmenopause; Progesterone Congeners | 2001 |